Latest News Apr 23, 2026 Esperion to Report First Quarter 2026 Financial Results on May 7 Apr 02, 2026 Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray) View All News Latest Quarterly Earnings Results Corporate Presentation ESPR Company Presentation - March 2026 6.6 MB Investor Events Upcoming Events May 7, 2026 8:00 AM EDT First Quarter 2026 Financial Results Past Events Apr 13, 2026 9:30 AM EDT 25th Annual Needham Virtual Healthcare Conference Mar 11, 2026 8:25 AM EDT The 2026 Citizens Life Sciences Conference View All Events
Apr 02, 2026 Esperion Therapeutics Closes Acquisition of Corstasis Therapeutics, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)